| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.024 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |